Ocugen, Inc. has grown revenue 21% a year over three years and 152% a year over five. Revenue growth, 3-year annual rate: +21% (Biotechnology median +17%). Revenue growth, 5-year rate: +152%, growth has slowed since the five-year average. Years of annual history on file: 12, FY2014 to FY2025, as filed.

OCGNOcugen, Inc.

Healthcare

$0.98-44% 1Y

$0.98

$0.9852 weeks$2.48

Latest close: a new 52-week lowOct 8, 2026what changed →

Is it growing?

Is OCGN growing?

Ocugen, Inc. has grown revenue 21% a year over three years and 152% a year over five.

+21%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +152%
Revenue growth, 5-year rate · +21% over three · growth has slowed since the five-year average
Years of annual history on file: 12
Years of annual history on file · FY2014 to FY2025, as filed

Details›